Publisher： Bentham Science Publishers
E-ISSN： 1873-5576|16|1|43-52
ISSN： 1568-0096
Source： Current Cancer Drug Targets, Vol.16, Iss.1, 2016-01, pp. : 43-52
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bevacizumab: In First-Line Treatment of Metastatic Breast Cancer
Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. :
Access to resources
Recommend
First-Line Treatment Strategies to Improve Survival in Patients with Advanced Colorectal Cancer
By Gill S.
Drugs, Vol. 64, Iss. 1, 2004-01 ,pp. :
Pertuzumab: In the First-Line Treatment of HER2-Positive Metastatic Breast Cancer
Drugs, Vol. 72, Iss. 3, 2012-02 ,pp. :
Bevacizumab in First-Line Treatment of Metastatic Breast Cancer: A Viewpoint by David Miles
By Miles David
Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. :